Kidney Week

Abstract: TH-PO1150

Effect of Curcumin on Vascular and Cognitive Function in CKD: A Randomized Controlled Trial

Session Information

• Late-Breaking Posters
  November 02, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

• 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

• Gimblet, Colin J., The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Colin J. Gimblet,

• Kruse, Nicholas T, Central Michigan University, Mount Pleasant, Michigan, United States

Nicholas T Kruse,

• Geasland, Katharine M., The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Katharine M. Geasland,

• Michelson, Jeni, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Jeni Michelson,

• Sun, Mingyao, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Mingyao Sun,

• Ten Eyck, Patrick, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Patrick Ten Eyck,

• Sambharia, Meenakshi, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Meenakshi Sambharia,

• Rossman, Matthew, University of Colorado Boulder, Boulder, Colorado, United States

Matthew Rossman,

• Linkenmeyer, Carinda, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Carinda Linkenmeyer,

• Tamura, Manjula, Stanford University, Stanford, California, United States

Manjula Tamura,

• Chonchol, Michel, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Michel Chonchol,

• Seals, Douglas R., University of Colorado Boulder, Boulder, Colorado, United States

Douglas R. Seals,

• Hoth, Karin, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Karin Hoth,

• Jalal, Diana I., The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States

Diana I. Jalal,

Background

Chronic kidney disease (CKD) increases the risk of developing cardiovascular disease (CVD) and cognitive impairment. Curcumin is a polyphenol that has been reported to improve vascular and cognitive function in middle-aged and older adults, however its effects on vascular and cognitive function in patients with CKD are unknown. We hypothesized that 12-month curcumin supplementation would improve vascular and cognitive function in patients with CKD.

Methods

88 adults with CKD (stage 3B or 4) participated in a 12-month, randomized, double-blind, placebo-controlled, parallel-arms intervention to examine the effects of curcumin (Longvida, 2000 mg/day) on vascular and cognitive function. Our primary outcomes were endothelial function and aortic stiffness determined from brachial artery flow-mediated dilation (FMD) and carotid-femoral pulse wave velocity (cfPWV), respectively. Our secondary outcomes were endothelium- independent dilation via nitroglycerin mediated dilation and cognitive function assessed via the NIH Toolbox Cognition Battery.

Results

75% of the participants were male, 56% had diabetes, and 15% had a history of CVD. The mean±SD age and eGFR were 66±8 years and 34.7±10.8 ml/min/1.73m2, respectively. The median (IQR) UACR was 81.9 mg/g (9.7-417.3). Following 12-months of curcumin supplementation, we observed no change in brachial artery FMD, nitroglycerin mediated dilation, or cfPWV (P>0.05; Table 1). Additionally, we observed no change in processing speed, executive function, memory, or language (P>0.05; Table 1). eGFR, UACR, hemoglobin A1c, and blood pressure were unchanged (P>0.05).

Conclusion

12-month curcumin supplementation did not change vascular or cognitive function in patients with CKD.

Change in primary and secondary outcomes according to study group

*Age-adjusted T-score

Funding

• Other NIH Support